Research

NCT06853912 - Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)

Clinical Trial in Seattle, Washington

NCT06853912, also referenced as PsiloStudy, is a University of Washington state-funded trial of psilocybin with psychological support for military veterans and first responders with co-occurring PTSD and alcohol use disorder. Source notes describe a single 25 mg psilocybin dose, non-directive psychological support, and integration therapy, with enrollment opening in early 2025. This is a research trial, not a public commercial service.

Clinical TrialIntegrationResearchVeteran Friendly
NCT06853912 - Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)

What They List

  • Psilocybin Clinical Trial
  • Study Screening Information
  • Research Participation Details

Directory Facts

Status
Verified from official/source records
Price
Free study screening / research participation
Hours
Verify with provider
License / Record
NCT06853912
Last Verified
2026-06-15

Location

University of Washington Center for Novel Therapeutics in Addiction Psychiatry, Seattle, Washington

Source Notes

Washington complete dataset reconciliation from supplied 2026-06-15 prompt.

Source: ClinicalTrials.gov NCT06853912; UW Newsroom; Washington complete dataset prompt

Informational listing only.

MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.